Dr Reddys Laboratories launches Pyrimethamine Tablets
Capital Market Dr Reddys Laboratories announced the launch of Pyrimethamine Tablets USP, 25 mg, a therapeutic equivalent and first-wave generic version of Daraprim (pyrimethamine) Tablets, approved by the U.S. Food and Drug Administration (USFDA). This product is the only AB-rated generic version Daraprim (pyrimethamine) Tablets approved by the USFDA.
Powered by Capital Market - Live News